U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.1525C>T (p.Pro509Ser) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting classifications of pathogenicity (3 submissions)
Last evaluated:
Mar 5, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000116004.21

Allele description [Variation Report for NM_007194.4(CHEK2):c.1525C>T (p.Pro509Ser)]

NM_007194.4(CHEK2):c.1525C>T (p.Pro509Ser)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.1525C>T (p.Pro509Ser)
Other names:
p.P509S:CCC>TCC
HGVS:
  • NC_000022.11:g.28689152G>A
  • NG_008150.2:g.57715C>T
  • NM_001005735.2:c.1654C>T
  • NM_001257387.2:c.862C>T
  • NM_001349956.2:c.1324C>T
  • NM_007194.4:c.1525C>TMANE SELECT
  • NM_145862.2:c.1438C>T
  • NP_001005735.1:p.Pro552Ser
  • NP_001244316.1:p.Pro288Ser
  • NP_001336885.1:p.Pro442Ser
  • NP_009125.1:p.Pro509Ser
  • NP_665861.1:p.Pro480Ser
  • LRG_302t1:c.1525C>T
  • LRG_302:g.57715C>T
  • LRG_302p1:p.Pro509Ser
  • NC_000022.10:g.29085140G>A
  • NM_007194.3:c.1525C>T
  • p.P509S
Protein change:
P288S
Links:
dbSNP: rs587780179
NCBI 1000 Genomes Browser:
rs587780179
Molecular consequence:
  • NM_001005735.2:c.1654C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001257387.2:c.862C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349956.2:c.1324C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007194.4:c.1525C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145862.2:c.1438C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Hereditary neoplastic syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000186790Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Mar 5, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV000902768Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Mar 3, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002537390Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Nov 16, 2021)
germlinecuration

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Kleiblová P, Stolařová L, Křížová K, Lhota F, Hojný J, Zemánková P, Havránek O, Vočka M, Černá M, Lhotová K, Borecká M, Janatová M, Soukupová J, Ševčík J, Zimovjanová M, Kotlas J, Panczak A, Veselá K, Červenková J, Schneiderová M, Burócziová M, Burdová K, et al.

Klin Onkol. 2019 Summer;32(Supplementum2):36-50. doi: 10.14735/amko2019S36.

PubMed [citation]
PMID:
31409080

Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk.

Boonen RACM, Wiegant WW, Celosse N, Vroling B, Heijl S, Kote-Jarai Z, Mijuskovic M, Cristea S, Solleveld-Westerink N, van Wezel T, Beerenwinkel N, Eeles R, Devilee P, Vreeswijk MPG, Marra G, van Attikum H.

Cancer Res. 2022 Feb 15;82(4):615-631. doi: 10.1158/0008-5472.CAN-21-1845.

PubMed [citation]
PMID:
34903604
PMCID:
PMC9359737
See all PubMed Citations (12)

Details of each submission

From Ambry Genetics, SCV000186790.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000902768.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002537390.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (9)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 13, 2025